The objective of this research was to understand the processes and outputs from different European p...
Read moreNICE has recently developed the META tool, to support MedTech manufacturers in the identification of...
Read moreSetting the price abtaining market access for a new pharmaceutical remains one of the biggest commer...
Read moreBiosimilars are becoming more widely available across Europe, with many payers at each level involve...
Read moreThe aim of this study is to compare the key aspects companies must consider when seeking HTA scienti...
Read moreOrphan drugs have important societal value as they improve patient quality of life and address unmet...
Read moreThis research highlights the variability regarding the scientific advice submission processes and sc...
Read moreUnderstanding payer value and evidence requirements to secure pricing and reimbursement for a novel ...
Read moreThe new NICE oncology appraisal process aims to enable fast-track appraisals, allowing earlier acces...
Read moreHow the pharmaceutical industry is investing in market access training capabilities to address today...
Read more